Orchard Therapeutics PLC
Jamie Morton is a highly experienced professional in CSV and quality compliance, currently serving as Senior Manager at Orchard Therapeutics since June 2023. With a diverse background, Jamie has held significant roles including Chief Business Development Officer at Validions Ltd and Director at JSM Compliance Ltd. Past experience includes consulting roles at various companies, focusing on CSV projects, IT compliance, and data integrity within the pharmaceutical and biotech sectors. Jamie's academic background includes a Bachelor's Degree in Biology Technician/Biotechnology Laboratory Technician from the University of Kent.
This person is not in the org chart
This person is not in any teams
Orchard Therapeutics PLC
3 followers
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.